NANOVIRICIDES, INC. Derivative, Fair Value, Net
NANOVIRICIDES, INC. (NNVC) had Derivative, Fair Value, Net of $5.70 million as of 2014-06-30, per its 10-K filed 2015-02-23.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:DerivativeFairValueOfDerivativeNet · last filed 2015-02-23
- 2014-06-30: Derivative, Fair Value, Net $5.70M.
- 2013-06-30: Derivative, Fair Value, Net $3.82M.
- 2013-01-15: Derivative, Fair Value, Net $2.74M.
- 2012-12-31: Derivative, Fair Value, Net $2.74M.
| Period end | Derivative, Fair Value, Net |
|---|---|
| 2014-06-30 | $5.70M 10-K · filed 2015-02-23 |
| 2013-06-30 | $3.82M 10-K · filed 2015-02-23 |
| 2013-01-15 | $2.74M 10-Q/A · filed 2013-05-20 |
| 2012-12-31 | $2.74M 10-K/A · filed 2013-10-08 |
| 2012-06-28 | $1.09M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |